子痫前期并发围产期心肌病早期识别及干预

doi:10.7504/fk2014090108

摘要/Abstract

摘要：

子痫前期和围产期心肌病(PPCM)存在共同的发病因素，二种疾病可以各自独立存在，亦可并存。一旦这二种妊娠期特发疾病同时存在将严重威胁母儿安全。因此，子痫前期患者有条件者尽可能早期行心脏超声及相应辅助检查，明确是否存在心功能减退或者合并存在PPCM，便于早期治疗。

关键词: 围产期心肌病, 子痫前期

Abstract:

Abstract: There are same risk factors for preeclampsia and peripartum cardiomyopathy. These two pregnancy-associated diseases can either exist independently or coexist. Once these two diseases coexist, maternal and perinatal health would be seriously threatened. Therefore, the patients with preeclampsia，especially severe preeclampsia,should undergo echocardiography and other accessory examinations as soon as possible in order to identify early PPCM or cardiac dysfunction and manage them.

Key words: peripartum cardiomyopathy, preeclampsia

中图分类号:

R714.24+4

林建华，赵卫秀. 子痫前期并发围产期心肌病早期识别及干预[J]. 中国实用妇科与产科杂志, DOI: 10.7504/fk2014090108.

LIN Jian-hua, ZHAO Wei-xiu.. Early identification and intervention of preeclampsia complicated by peripartum cardiomyopathy.[J]. Acta Metallurgica Sinica, DOI: 10.7504/fk2014090108.

参考文献

[1］ Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the heart failure association of the European Society of Cardiology Working Group on peripartum cardiomyopathy［J］.Eur J Heart Fail,2010,12:767-778.

[2］ Bello N, Rendon IS, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis［J］.J Am Coll Cardiol,2013,62:1715-1723.

[3］ Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sflt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia［J］.J Clin Invest,2003,111:649-658.

[4］ Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia［J］.Circ Res,2004,95:884-891.

[5］ Patten IS, Rana S, Shahul S, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy［J］.Nature,2012,485:333-338.

[6］ McMurray JJ, Adamopoulos S, Anker SD, et al. Esc guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology developed in collaboration with the heart failure association (hfa) of the esc［J］.Eur Heart J,2012,33:1787-1847.

[7］ Johnson-Coyle L, Jensen L, Sobey A. Peripartum cardiomyopathy: review and practice guidelines［J］.Am J Crit Care,2012,21:89-98.

[8］ Atalay C, Erden G, Turhan T, et al. The effect of magnesium sulfate treatment on serum cardiac troponin levels in preeclamptic women［J］.Acta Obstet Gynecol Scand,2005,84:617-621.

[9］ Coates BJ, Broderick TL, Batia LM, et al. Mgso4 prevents left ventricular dysfunction in an animal model of preeclampsia［J］.Am J Obstet Gynecol,2006,195:1398-1403.

[1]	生殖健康及重大出生缺陷防控研究高龄产妇妊娠期并发症防治策略研究项目组. 子痫前期防治的集束化管理建议[J]. 中国实用妇科与产科杂志, 2022, 38(5): 534-537.
[2]	万书婷, 王谢桐, . 子宫动脉血流监测在产科的应用[J]. 中国实用妇科与产科杂志, 2022, 38(4): 403-406.
[3]	王一男, 李笑天. 子痫前期临床表现异质性与发病机制的关联性[J]. 中国实用妇科与产科杂志, 2022, 38(2): 138-141.
[4]	赫英东, 陈倩. 子痫前期并发症之外的HELLP综合征[J]. 中国实用妇科与产科杂志, 2022, 38(2): 145-149.
[5]	杨孜. 识子痫前期综合征病因关联再分类提升精准医疗之高度[J]. 中国实用妇科与产科杂志, 2022, 38(1): 13-17.
[6]	杨孜. 子痫前期综合征分类分层分级管理——制胜临床实践之方向[J]. 中国实用妇科与产科杂志, 2021, 37(5): 505-511.
[7]	漆洪波，胡小靖. 妊娠期高血压疾病产前保健的“六个重视”[J]. 中国实用妇科与产科杂志, 2021, 37(5): 512-514.
[8]	肖喜荣，李笑天. sFlt-1/PlGF预测子痫前期的临床局限性和实践探索方向[J]. 中国实用妇科与产科杂志, 2021, 37(5): 515-519.
[9]	赫英东，陈倩. 阿司匹林预防子痫前期的局限性和临床应用选择[J]. 中国实用妇科与产科杂志, 2021, 37(5): 519-522.
[10]	张勤建，颜建英. 基层医院如何防控子痫前期[J]. 中国实用妇科与产科杂志, 2021, 37(5): 522-526.
[11]	高劲松，刘俊涛. 存在母体基础疾病者预防子痫前期的临床重点[J]. 中国实用妇科与产科杂志, 2021, 37(5): 526-531.
[12]	沈鸿飞，李佳钋. 双胎妊娠子痫前期预防和处理[J]. 中国实用妇科与产科杂志, 2021, 37(5): 531-535.
[13]	贺晶，洪燕语. 早发子痫前期不同级别医院的管理[J]. 中国实用妇科与产科杂志, 2021, 37(5): 539-542.
[14]	刘晓夏，邹丽. 强化对子痫前期及HELLP综合征在产时产后的认知和管理[J]. 中国实用妇科与产科杂志, 2021, 37(5): 542-546.
[15]	许煌坊，李笑天. 子痫前期患者远期罹患全身各系统疾病风险及防范[J]. 中国实用妇科与产科杂志, 2021, 37(2): 142-145.